Postdoctoral Position - RAS Pharmacology & RAS Systems Biology– Stites Laboratory
An experimental postdoctoral position is available to study emerging RAS and RAS pathway inhibitors. RAS inhibitors are one of the most exciting areas of cancer biology. Many novel strategies for targeting RAS are in clinical trial, and many more are in development and are advancing to clinical trials.
The Stites lab’s translational cancer biology research program has helped postdoctoral fellows obtain outstanding career positions in industry and in academia. The Stites lab investigates problems in cancer biology and in cancer pharmacology that would benefit from a systems biology approach.
The lab’s first experimental postdoctoral fellow investigated relationships between RAS pathway inhibitors and targeted therapies in collaboration with the (computational) PI. The experimental/computational collaboration was very productive (McFall T et al, Science Signaling, 2019; McFall T et al, Cell Reports, 2021; McFall T et al, npj Precision Oncology, 2022; McFall T et al, Cell Communication and Signaling, 2021; Kato and McFall et al, The Oncologist, 2021). The lab is prepared to make a similar investment of time and resources to help a highly motivated postdoctoral fellow advance their career through a postdoctoral fellowship that investigates RAS inhibitors and their effects on RAS signaling and RAS signaling phenotypes.
Requirements for the position include a doctoral degree, one or more first author research publications demonstrating strong and relevant experimental biology skills, and previous experience in pharmacology, cancer biology, cell signaling, and/or cellular biochemistry.
Additional information about the laboratory, research interests, completed research projects, and the excellent career trajectories of previous postdoctoral fellows and lab members is available on the laboratory website: https://www.stiteslab.org/
Interested candidates should send contact Ed Stites, MD, PhD at research@stiteslab.org and (1) provide a current CV, (2) explain why the candidate is interested in the laboratory and in research involving RAS inhibitors.